Early induction of secretoneurin expression following kainic acid administration at convulsant doses in the rat and gerbil hippocampus

Hippocampus

Volumn 12, Issue 2, 2002, Pages 174-185

  Marti, E ^a,c   Blasi, J ^a   Ferrer, I ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Facultat de Medicina   (Spain)

Author keywords

Calcium binding proteins; Chromogranin; Excitotoxicity; Immunohistochemistry; Protein expression

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; EXCITOTOXIN; KAINIC ACID; PARVALBUMIN; SECRETOGRANIN II; SECRETONEURIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CONVULSION; ENTORHINAL CORTEX; GERBIL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MORPHOLOGY; NERVE CELL LESION; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PYRAMIDAL NERVE CELL; RAT; SPECIES DIFFERENCE;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHROMOGRANINS; CONVULSANTS; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; GABA ANTAGONISTS; GERBILLINAE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; NEUROPEPTIDES; ORGANOPHOSPHORUS COMPOUNDS; PARVALBUMINS; PHOSPHINIC ACIDS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; SECRETOGRANIN II;

EID: 0036228701     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.1103     Document Type: Article

References (37)

1. Sustained dopamine release induced by secreto-neurin in the striatum of the rat: A microdialysis study
2. Comparative in vivo and in vitro studies with the potent GABAb receptor antagonist, CGP 56999A
3. Multiple neurotrophic signals converge in surviving CA1 neurons of the gerbil hippocampus following transient forebrain ischemia
4. Differential c-fos and caspase expression following kainic acid excitotoxicity
5. Secretogranin II is synthesized and secreted in astrocyte cultures
6. Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin
7. Seizures induce distinctly different changes in enkephalin, dynorphin and CCK in the mouse hippocampal mossy fibers
8. Focal hippocampal lesions induce seizures and long-lasting changes in mossy fiber enkephalin and CCK
9. The primary structure of rat secretogranin II deduced from cDNA sequence
10. Binding of [H3]MK801, NMDA-displaceable [3H]glutamate, [3H]glycine, [3H]spermidine, [3H]kainate and [3H]AMPA to regionally discrete brain membranes of the gerbil: A biochemical study
11. Secretoneurin-a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin-II (chromogranin C)
12. Human and rat C-fibre afferents store and release secretoneurin, a novel neuropeptide
13. Secretoneurin and chemoattractant receptor interactions
14. Kainate-evoked secondary gene expression in the rat hippocampus
15. The calretinin-containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity-induced neuropathological changes in the gerbil and rat
16. Temporal lobe epilepsy of the rat: Differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfields of the hippocampus
17. Distribution of secretoneurin, a peptide derived from secretogranin-II, in rat brain: An immunocytochemical and radioimmunological study
18. Spiny calretinin-immunoreactive neurons in the hilus and CA3 region of the rat hippocampus: Local axon circuits, synaptic connection and glutamic acid decarboxilase 65/67 mRNA expression
19. Distribution of parvalbumin-containing interneurons in the hippocampus of gerbil: A qualitative and quantitative statistical analysis
20. The parvalbumin-containing nonpyramidal neurons in the rat hippocampus
21. Comparison of in vitro ischemia-induced disturbances in energy metabolism and protein synthesis in the hippocampus of rats and gerbils
22. Kainic acid inhibits protein amino cid incorporation in select brain regions
23. Attraction of human monocytes by the neuropeptide secretoneurin
24. Secretoneurin releases dopamine from rat striatal slices. A biological effect of a peptide derived from secretogranin II (chromogranin C)
25. Secretoneurin: A marker in rat hippocampal pathways
26. Widespread patterns of neuronal damage following systemic or intracerebral injections of KA: A histological study
27. Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: Effect of treatments including seizures, osmotic stimulation and axotomy in the rat
28. Comparison of neuronal responses to experimental ischemia in gerbil and rat hippocampal slices
29. Resistance to epileptic, but not anoxic, depolarization in the gerbil hippocampal slice preparation
30. KA induced seizures: Neurochemical and histopathological changes
31. KA-induced seizures: Dose-relationship of behavioural, neurochemical and histopathological changes
32. Poor correlation between neuronal death induced by transient forebrain ischemia, and immunoreactivity for parvalbumin and calbindin D-28k in developing gerbil hippocampus
33. Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: Their immunoreactivity for GABA and projection to the medial septum
34. Release of secretoneurin and noradrenaline from hypothalamic slices and its differential inhibition by calcium channel blockers
35. Opposite effects of GABAB receptor antagonists on absences and convulsive seizures
36. Chromogranins in rat brain: Characterization, topographical distribution and regulation of synthesis
37. Effects of secretogranin-II derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis